Radar on Drug Benefits

Walmart’s Discount Insulin Could Attract Insured Customers

Walmart Inc. — which like Amazon has been diving deeper and deeper into health care — recently made one of its biggest moves yet in that space by partnering with Novo Nordisk to launch private-label insulin at a...
0 Comments
© 2024 MMIT

States Start to Take Advantage of New Authority Over PBMs

State governments have begun to pursue aggressive policies to make PBMs more transparent, accountable to plan sponsors and less expensive to contract with — efforts that are bolstered by Rutledge v. Pharmaceutical...
0 Comments
© 2024 MMIT

News Briefs

✦ EmployersRX, a coalition of organizations representing health care purchasers that aims to bring down drug costs, has joined the growing number of groups expressing concern about the cost of a recently approved ...
0 Comments
© 2024 MMIT

New Starts of Psychotropic Medications Dropped During COVID-19

New starts of antidepressants declined by 7.5%, anxiolytics by 5.6%, and antipsychotics by 2.6% compared with forecast levels during the first five months of the COVID-19 pandemic, according to a new study published...
0 Comments
© 2024 MMIT

Moody’s Is Bullish on Pharma Industry for Next 18 Months

The pharmaceutical industry should continue to enjoy strong financial results in the next 12 to 18 months, according to a new report from Moody’s Investors Service. The credit ratings firm projects 4% to 6% growth...
0 Comments
© 2024 MMIT

Blues-Funded Startup Aims to Boost Value-Based Drug Pacts

In a move that signals Blue Cross Blue Shield plans are getting increasingly serious about driving down the cost of prescription drugs, five major Blues affiliates on June 22 launched a startup company that aims to ...
0 Comments
© 2024 MMIT

News Briefs

✦ HHS said on June 9 that the U.S. government will procure approximately 1.7 million courses of Merck & Co.’s investigational antiviral treatment for COVID-19, molnupiravir (MK-4482), pending emergency use a...
0 Comments
© 2024 MMIT

Payers Create CAR-T Approval Systems as Adoption Increases

Spurred by CMS’s decision to cover chimeric antigen receptor T-cell therapies under Medicare, commercial payers are beginning to systematize approvals for CAR-T treatment as use of these breakthrough cancer therap...
0 Comments
© 2024 MMIT

Amazon Plans to Offer 6-Month, Discount Generic Rx Fills

Amazon.com, Inc. launched a long-anticipated expansion of its pharmacy business on June 8, saying it will allow Prime members to purchase up to six-month supplies of generic prescription drugs for $6. Experts say Am...
0 Comments
© 2024 MMIT

Small Business Owners Want Big Changes to Lower Drug Costs

Almost 90% of small business owners said the cost of prescription drugs is too high and 63% have an unfavorable view of pharmaceutical companies, according to a recent survey of 1,052 small business owners conducted...
0 Comments
© 2024 MMIT